SCHEMBL30890210

SCHEMBL30890210

CC(C)(C)OC(=O)N1CC2(C1)CN(c1c(F)cc([N+](=O)[O-])cc1F)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
PARP1 P09874 2/20 0.39
KCNH2 Q12809 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
RORC P51449 1/20 0.38
HDAC2 Q92769 2/20 0.37
HDAC1 Q13547 1/20 0.37
EGLN2 Q96KS0 1/20 0.37
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
THRB P10828 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NR1H2 P55055 1/20 0.34
CYP11B2 P19099 1/20 0.34
GPR183 P32249 1/20 0.34
ACACB O00763 1/20 0.34
MET P08581 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29888814 0.87 ALDH1A1 (0.49) MAPTALDH1A1LMNAPARP1KCNH2
SCHEMBL16013943 0.86 ALDH1A1 (0.48) MAPTALDH1A1LMNAKCNH2GPR119
SCHEMBL22179574 0.85 ALDH1A1 (0.51) MAPTALDH1A1LMNAPARP1THRB
SCHEMBL31548463 0.85 ALDH1A1 (0.51) MAPTALDH1A1LMNAPARP1THRB
SCHEMBL31639802 0.85 ALDH1A1 (0.44) MAPTALDH1A1LMNAGPR119
SCHEMBL2448576 0.84 MAPT (0.64) MAPTALDH1A1LMNAKCNH2GPR119
SCHEMBL27406158 0.84 PARP1 (0.42) PARP1GPR119RORCHDAC2HDAC1
SCHEMBL30890214 0.83 HDAC2 (0.41) PARP1GPR119RORCHDAC2HDAC1
SCHEMBL27406159 0.83 USP30 (0.43) PARP1GPR119RORCHDAC2HDAC1
SCHEMBL12005382 0.80 MAPT (0.71) MAPTALDH1A1LMNAGPR119EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
WO-2024108009-A1 DYRK/CLK PROTACS AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2024-05-23 WO disclosed